GK
George Kemble sold $3.6M of SGMT stock
George Kemble, Dir of Sagimet Biosciences Inc. (SGMT), sold 350,987 shares of SGMT stock worth $3.6M, per an SEC Form 4 filed Aug 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 14, 2026, 3 days before it was made public.
SGMT has moved -6.6% since the trade date, from $10.55 to $9.85 (Nov 17, 2026 close).
- Traded
- Aug 14, 2026
- Disclosed
- Aug 17, 2026
- Filing delay
- 3 days
- Price since
- -6.6%
- Role
- Dir
- Source
- SEC Form 4